Frontier in Medical & Health Research
Vol. 4 No. 3 (2026), Articles
Vol. 4 No. 3 (2026)

LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Articles
Published 2026-03-31
  • FNU Kanwal
  • FNU Vishal
  • Daim Ahmed Shahid
  • Fareena Waseem
  • Dr Yasra Memon
  • Dr. Khaja Farazuddin
  • Manesh Kumar
  • Newton Rahming
FNU Kanwal
FNU Vishal
Daim Ahmed Shahid
Fareena Waseem
Dr Yasra Memon
Dr. Khaja Farazuddin
Manesh Kumar
Newton Rahming
PDF

Keywords

SGLT2 inhibitors, dapagliflozin, empagliflozin, non-diabetic chronic kidney disease, CKD progression, eGFR, cardiovascular outcomes, systematic review, and meta-analysis, IgA nephropathy, renoprotection, DAPA-CKD

How to Cite

LONG-TERM CARDIOVASCULAR AND RENAL OUTCOMES OF SGLT2 INHIBITORS IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2026). Frontier in Medical and Health Research, 4(3), 3196-3217. https://fmhr.net/index.php/fmhr/article/view/3537
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Use the pdf link

PDF